1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Molecule Type 41
3.1 Market Overview by Molecule Type 41
3.2 Small Molecule 43
3.3 Large Molecule 44
4 Segmentation of Asia Pacific Market by Drug Class 45
4.1 Market Overview by Drug Class 45
4.2 Monoclonal Antibodies (mAbs) 47
4.3 Immunoglobulin 48
4.4 Insulin 49
4.5 Vaccines 50
4.6 Cytokines 51
4.7 Peptide Hormone 52
4.8 Blood Factors 53
4.9 Other Drug Classes 54
5 Segmentation of Asia Pacific Market by Delivery 55
5.1 Market Overview by Delivery 55
5.2 Pre-filled Syringe 57
5.3 Infusions 58
5.4 Other Deliveries 59
6 Segmentation of Asia Pacific Market by Application 60
6.1 Market Overview by Application 60
6.2 Oncology 62
6.3 Infectious Diseases 63
6.4 Autoimmune Diseases 64
6.5 Cardiovascular Diseases 65
6.6 Pain 66
6.7 Neurology 67
6.8 Other Applications 68
7 Segmentation of Asia Pacific Market by Distribution Channel 69
7.1 Market Overview by Distribution Channel 69
7.2 Hospital Pharmacy 71
7.3 Retail Pharmacy 72
7.4 E-Commerce 73
8 Asia-Pacific Market 2019-2030 by Country 74
8.1 Overview of Asia-Pacific Market 74
8.2 Japan 77
8.3 China 80
8.4 Australia 82
8.5 India 85
8.6 South Korea 87
8.7 Rest of APAC Region 89
9 Competitive Landscape 91
9.1 Overview of Key Vendors 91
9.2 New Product Launch, Partnership, Investment, and M&A 94
9.3 Company Profiles 95
Amgen Inc. 95
Baxter International Inc. 97
Eli Lilly and Company 98
Gilead Sciences Inc. 99
GlaxoSmithKline PLC 100
Johnson & Johnson 101
Merck & Co. Inc. 102
Moderna, Inc. 103
Novartis AG 104
Novo Nordisk AS 105
Pfizer Inc. 106
Sanofi SA 107
Teva Pharmaceuticals Industries Ltd. 108
RELATED REPORTS 109